WO1999061911A2 - Nanometer particles containing a reactive monolayer - Google Patents
Nanometer particles containing a reactive monolayer Download PDFInfo
- Publication number
- WO1999061911A2 WO1999061911A2 PCT/US1999/007823 US9907823W WO9961911A2 WO 1999061911 A2 WO1999061911 A2 WO 1999061911A2 US 9907823 W US9907823 W US 9907823W WO 9961911 A2 WO9961911 A2 WO 9961911A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- monolayer
- mixtures
- core
- particle according
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0043—Preparation of sols containing elemental metal
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
Definitions
- the invention generally relates to nanometer-sized particles which have been chemically modified and methods of making the same.
- nanotechnology relates to the art and science of building molecular materials so that they are capable of functioning as macro-scale structures and/or exhibiting physical and chemical properties which are intermediate between molecular and bulk materials. Applications involving nanotechnology are potentially far reaching. Areas of possible interest relate to, for example, catalysis, molecular electronics, biotechnology, composite materials, solar energy conversion, and the like. Investigative efforts regarding nanotechnology have focused largely on understanding the physical behavior and structure of nanometer-sized materials. Reiss, H., Proceedings of the Welch Foundation 39 th Conference on Chemical Research: Nanophase Chemistry (1995) 49-66 discusses thermodynamic behavior associated with nanophase technology.
- Nanometer-sized gold particles can be chemically attached to metal surfaces, such as electrodes.
- the purpose of such experiments is to allow the researcher to add functionality onto the immobilized particles in order to add value to the metal surface.
- Metal sols are small particles which are insoluble, and thus suspended, in the liquid in which they are dispersed. Numerous recent studies have investigated methods for adding to the complexity of metal sols. For example, Mirkin, C.A., et al., Nature 382 (1996) 607-609, proposes attaching oligonucleotides to gold sols in order to promote aggregation of said sols upon addition of an appropriate complementary oligonucleotide to the sol solution.
- U.S. Patent No. 4,859,612 to Cole et al. proposes that antibody coated metal sols can interact with an appropriately coated solid phase particle as a means for an immunoassay procedure.
- Soc, 117:50 (1995) 12537-12548 proposes nanometer- sized gold cores which are stabilized by chemisorbed layers of octane- or hexadecanethiolate. These monolayer-protected gold clusters were found to be highly stable as determined by differential scanning calorimetry techniques.
- Hostetler, M.J., et al., Langmuir, 12 (1996) 3604-3612 relates to the evaluation of the physical structure of alkanethiolates of various chain lengths adsorbed onto nanometer-sized gold cores. Alkanethiolates with shorter chain lengths were determined to be relatively disordered while materials with longer chain lengths were found to be in the trans zig-zag conformation.
- the previous three descriptions of the art represent nanometer-sized gold cores covered with simple, non-derivatized alkanethiols, a circumstance that severely limits their applicability.
- nanometer-sized materials which exhibit specific chemical and physical properties. More particularly, there is a need for such materials which can be tailored for utilization in a number of defined end use applications. It would be particularly desirable if the nanometer-sized particles exhibited flexible chemical behavior as well as
- the invention relates to a functionalized nanometer- sized particle comprising a core which comprises at least one metal or metal 120 alloy; and a monolayer chemically bonded to the core.
- the monolayer is formed during the formation of the core and can be modified at any time following formation of the core.
- the monolayer contains at least one reactive substituent thereon which is coupled to a functional material such that the monolayer becomes chemically modified.
- the reactive substituent may be 125 selected from a number of groups such as, for example, SH, OH, NH 2 , NH, C0 2 H, SO 3 OH, P0 2 (OH) 2 , BO(OH) 2 , or mixtures thereof.
- a number of functional materials may be employed such as catalysts, biomaterials, and materials which are chemically, electrochemically, or photochemically active.
- the particles may be readily
- the invention in another aspect, relates to a method of making a functionalized nanometer-sized particle.
- the method comprises providing a nanometer-sized particle comprising: (1) a core which comprises at least one metal or metal alloy and (2) a monolayer chemically bonded to the core, the
- the nanometer-sized particle is then coupled with a functional material such that the monolayer becomes chemically modified.
- this method allows for the particle to be modified based on a small subset of reactive substituents, all of which can be readily synthesized or purchased commercially. Adding greater value to said
- nanometer-sized particle can then be accomplished using a variety of functional materials.
- FIG. 1 is a representation of a multi-step synthesis of a tripeptide- functionalized monolayer-protected nanometer-sized gold core.
- FIG. 2a is a graph illustrating the electrochemical characterization of a 10H-(phenothiazine-10)propionic acid-functionalized monolayer-protected nanometer-sized gold core. Specifically, the figure illustrates the cyclic 150 voltammetry of 0.8 mM 70H-(phenothiazine-10)propionic acid (-) in 2:1 toluene/acetonitrile (v/v) at 10OmV/s; and
- the invention relates to a functionalized nanometer-sized particle.
- the functionalized nanometer-sized particle comprises a core
- the core preferably has a diameter ranging from about 1 nm to about 999 nm, more preferably from about 1 nm to about 100 nm; even more preferably from about 1 nm to about 20 nm; and most preferably from about 1 nm to about 7 nm.
- a monolayer is chemisorbed or chemically bonded to the core. The monolayer
- 170 contains at least one reactive substituent as described further herein.
- the reactive substituent(s) on the monolayer is/are coupled to a functional material so as to chemically modify the monolayer.
- metals and metal alloys may be used in the core.
- the metal or metal alloy is selected from the group consisting of
- a semiconducting material a metal oxide material, a Group VIIIA element, a
- the metal or metal alloy is selected from the group consisting of a Group VIIIA element, a Group IB element, alloys thereof, and mixtures thereof. Examples of elements which may be used include, but are not limited to, gold,
- Examples of semiconducting materials include, but are not limited to, cadmium sulfide, indium phosphide, and other Group lll-V materials.
- Example of oxide materials include, but are not limited to, titanium oxide (titania), aluminum oxide (alumina), tin oxide, and iron oxide.
- the shape of the core is not restricted to any particular 185 geometry, thus, for example, rods, spheres, cuboctahedra, and truncated octahedra, will all satisfy the conditions stated herein.
- the term "monolayer” may be defined as a layer preferably having a thickness ranging from about 0.4 nm to about 100 nm, and more preferably 1.0 to 20 nm.
- the monolayer is typically formed during the formation of the core, and the monolayer can be modified at any point following formation of the core.
- the monolayer which is adsorbed or chemically bonded to the core may comprise a number of materials. Examples of these materials include, but are not limited to, organic compounds (e.g., alkanethiols, arylthiols, vinylthiols,
- inorganic compounds e.g., alkyl borates, alkyl phosphonates, alkyl silicates), organometallic compounds (e.g., ferrocenethiol); biochemical compounds (e.g., cysteine, albumin, coenzyme A), and mixtures thereof.
- the monolayer include, for example, branched molecules
- the monolayer may comprise an alkanethiol or an alkanethiol derivative.
- Exemplary alkanethiols include those having between 2 and 23 carbon atoms.
- the monolayer contains at least one reactive substituent.
- reactive substituent refers to those substituents which are chemically active so that, upon reaction with a functional material, part of the reactive substituent remains with the
- reactive substituents include, but are not limited to, SH, OH, NH 2 , NH, C0 2 H, S0 3 OH, P0 2 (OH) 2 , BO(OH) 2 , and mixtures thereof. More preferably, OH, NH, C0 2 H, NH 2 , and mixtures thereof are employed. Examples of compounds which may be present
- R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof;
- E is selected from the group consisting of S, O, NH, COO,
- n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, C0 2 , NH 2 , and mixtures thereof.
- the chemically modified monolayer may also include partially reactive and nonreactive compounds or materials.
- nonreactive compounds or materials may be used in any ratio so long as at least one reactive compound or material is present on the monolayer.
- the monolayer is preferably chemically bonded to the core by various types of bonds.
- bonds include, but are not limited to, core- element-sulfur bonds, core-element-oxygen-bonds, core-element-boron, core-
- the monolayer is chemically bonded to the core by various core-element-sulfur bonds.
- core-element refers to any element of which the core is composed.
- the monolayer is coupled to a functional material such that the monolayer is chemically modified.
- the term "coupled” may be interpreted to mean that the monolayer and the functional material are linked via formation of a new chemical bond. Examples, include, but are not limited to amide, thioester, and ester-forming reactions known in the art.
- Examples of functionalities which may be present on the functional materials include, but are not limited to, SH, OH, NH 2 , NH, C0 2 H, S0 3 OH, P0 2 (OH) 2 , BO(OH) 2 , and mixtures thereof.
- Examples of reactive substituents include, but are not limited to, SH, OH, NH 2 , NH, C0 2 H, S0 3 OH, P0 2 (OH) 2 , BO(OH) 2 , and mixtures thereof. More preferably, OH, NH, C0 2 H, NH 2 , and mixtures thereof
- the functional material may also comprise at least one compound having the general formula:
- R n (EH) x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound,
- E is selected from the group consisting of S, O, NH, COO,
- n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, C0 2 , NH 2 , and mixtures thereof. It should be emphasized that the
- the functional material may be present in the form of a number of structures which possesses functionality in the manner described herein.
- the functional material may be a catalyst, a biomaterial, a material which is electrochemically active, or combinations thereof.
- the functional material may also be one which has a low-lying excited state which is capable of undergoing
- the functional material may also be selected such that the nanometer-sized particle is soluble in a solvent.
- soluble may be defined to mean the particles being dispersed or dissolved in the solvent.
- suitable solvents include aqueous or organic solvents.
- the invention relates to a method of making a functionalized nanometer-sized particle.
- the method comprises providing a nanometer-sized particle comprising a core which comprises at least one metal or metal alloy, and a monolayer adsorbed onto the core.
- the monolayer includes at least one reactive substituent.
- the nanometer-sized particle is then
- a number of functional materials may be used in the above method. Examples of these materials include, but are not limited to, spin labels (e.g., 4- amino-TEMPO), metal ligands (e.g., 4-(aminomethyl)-pyridine), amino acids
- chromophores and fluorophores e.g., 1- aminopyrene and 2-naphthaleneethanol
- ionophores e.g., 2-(aminomethyl)-15- crown-5
- molecules susceptible to functional group conversion e.g., benzyl amine
- electroactive molecules e.g., ferrocene methanol, " OH-(phenothiazine- 10) propionic acid, anthraquinone-2-carboxylic acid
- sugars e.g., ⁇ -D-glucose
- nucleotides e.g., uridine
- the coupling step is preferably carried out in the presence of a reagent which may be, for example, a phophonium reagent, a facilitating reagent, as well as mixtures thereof.
- a reagent which may be, for example, a phophonium reagent, a facilitating reagent, as well as mixtures thereof.
- the facilitating reagent may be selected from a base, a catalyst, and mixtures thereof.
- Preferred bases include various pyridine
- components which may be employed during the coupling step include, but are not limited to, BOP (benzotriazol-1- yloxytris(dimethylamino)phosphonium hexafluorophosphate); HOBt (1- hydroxybenzotriazole); NMM (4-methylmorpholine); DMAP (4- dimethylaminopyridine); and mixtures thereof
- the invention in another aspect, relates to a method of analyzing a nanometer-sized particle.
- the method comprises subjecting a nanometer-sized particle as defined herein to an analytical technique such that the composition of the functional materials of the monolayer on the particle are determined.
- an analytical technique such that the composition of the functional materials of the monolayer on the particle are determined.
- a number of analytical techniques may be employed in this method. Examples of
- such techniques include, but are not limited to, NMR spectroscopy, electrochemical techniques, fluorescent emission spectroscopies, and infrared spectroscopies. Examples
- 345 are those that are unique to each functionalized monolayer-protected nanometer-sized gold core (an infrared spectra of a nanometer-sized gold core which is stabilized by chemisorbed layers of dodecanethiolate was used for background subtraction).
- BOP benzotriazol-1- yloxytris(dimethylamino)phosphonium hexafluorophosphate
- HOBt 1- hydroxybenzotriazole
- NMM 4-methylmorpholine
- DMAP dimethylaminopyridine
- 4-amino-TEMPO 4-amino-2, 2,6,6-
- CD 2 CI 2 ⁇ (ppm) - 0.9 (br, 17 H), 1.3 (br, 150 H), 2.75 (br, 0.2 H), 4.0 (br, 2 H), 4.1 (br, 2 H), 6.8 (br, 5.9 H), 7.1 (br, 5.9 H)
- IR 2851 (d + ), 2921 (d ), 1817, 1733, 1700, 1633, 1616, 1491 , 1411 , 843, 782, 764, 742 cm "1 .
- the electrochemistry of this MPC derivative is shown in Figure 3a. The percent conversion to number 495 coupled ratio was determined to be 65/7.4.
- Cyclic voltammetry (seen in Figure 2) was performed with a BAS 100B electrochemical analyzer sold by Bioanalytical Systems, Inc., located in West Lafayette, Indiana. A platinum 3 mm diameter working electrode was polished with 0.5 ⁇ m diamond (Buehler) paste followed by rinsing with water, ethanol, and
- Thin-layer coulometry (as seen in Figure 2b) was performed using a BAS 590 100B electrochemical analyzer.
- a 4.3 mm diameter Pt working electrode was polished with 0.5 ⁇ m of diamond (Buehler) paste followed by rinsing with water, ethanol, and acetone and toluene prior to each experiment.
- a Pt wire counter electrode and Ag wire quasi-reference electrode (AgQRE) resided in a locally designed thin-layer cell as defined in Reilley, C.N., Pure Appl. Chem. 18 (1968) 595 137.
- a Mitutoyo digital micrometer (1-2", 0.00005" resolution) sold by Mitutoyo
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002329859A CA2329859A1 (en) | 1998-04-20 | 1999-04-09 | Nanometer particles containing a reactive monolayer |
EP99953384A EP1073902A2 (en) | 1998-04-20 | 1999-04-09 | Nanometer particles containing a reactive monolayer |
AU60169/99A AU6016999A (en) | 1998-04-20 | 1999-04-09 | Nanometer sized particles containing a reactive monolayer adsorbed thereon and methods of making the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6286398A | 1998-04-20 | 1998-04-20 | |
US09/062,863 | 1998-04-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999061911A2 true WO1999061911A2 (en) | 1999-12-02 |
WO1999061911A3 WO1999061911A3 (en) | 2000-03-09 |
Family
ID=22045338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/007823 WO1999061911A2 (en) | 1998-04-20 | 1999-04-09 | Nanometer particles containing a reactive monolayer |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1073902A2 (en) |
AU (1) | AU6016999A (en) |
CA (1) | CA2329859A1 (en) |
WO (1) | WO1999061911A2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002032404A2 (en) * | 2000-10-16 | 2002-04-25 | Consejo Superior De Investigaciones Cientificas | Nanoparticles |
US6483125B1 (en) | 2001-07-13 | 2002-11-19 | North Carolina State University | Single electron transistors in which the thickness of an insulating layer defines spacing between electrodes |
US6653653B2 (en) | 2001-07-13 | 2003-11-25 | Quantum Logic Devices, Inc. | Single-electron transistors and fabrication methods in which a projecting feature defines spacing between electrodes |
US6673717B1 (en) | 2002-06-26 | 2004-01-06 | Quantum Logic Devices, Inc. | Methods for fabricating nanopores for single-electron devices |
FR2859117A1 (en) * | 2003-08-27 | 2005-03-04 | Commissariat Energie Atomique | USE OF NANOPARTICLES WITH A METAL HEART AND DOUBLE ORGANIC COATING AS CATALYSTS AND NANOPARTICLES USEFUL AS CATALYSTS |
WO2004108165A3 (en) * | 2003-06-09 | 2005-06-16 | Consejo Superior Investigacion | Magnetic nanoparticles linked to a lingand |
CN1305977C (en) * | 2005-03-04 | 2007-03-21 | 北京化工大学 | Method for modifying the surface of nano inorganic particles by transfer method |
JP2008514686A (en) * | 2004-10-01 | 2008-05-08 | ミダテック リミテッド | Nanoparticles containing antigens and adjuvants, and immunogenic structures |
US7563818B2 (en) | 2001-11-01 | 2009-07-21 | Cancer Research Technology Limited | Photosensitizer functionalised nanoparticles |
US8597397B2 (en) | 2005-01-14 | 2013-12-03 | Cabot Corporation | Production of metal nanoparticles |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0426300A1 (en) * | 1989-09-29 | 1991-05-08 | Ortho Diagnostic Systems Inc. | Method of producing a reagent containing a narrow distribution of colloidal particles of a selected size and the use thereof |
EP0428412A2 (en) * | 1989-11-16 | 1991-05-22 | Ortho Diagnostic Systems Inc. | Method of producing a metal sol reagent containing colloidal metal particles of a preselected size |
-
1999
- 1999-04-09 WO PCT/US1999/007823 patent/WO1999061911A2/en not_active Application Discontinuation
- 1999-04-09 AU AU60169/99A patent/AU6016999A/en not_active Abandoned
- 1999-04-09 EP EP99953384A patent/EP1073902A2/en not_active Withdrawn
- 1999-04-09 CA CA002329859A patent/CA2329859A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0426300A1 (en) * | 1989-09-29 | 1991-05-08 | Ortho Diagnostic Systems Inc. | Method of producing a reagent containing a narrow distribution of colloidal particles of a selected size and the use thereof |
EP0428412A2 (en) * | 1989-11-16 | 1991-05-22 | Ortho Diagnostic Systems Inc. | Method of producing a metal sol reagent containing colloidal metal particles of a preselected size |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7364919B2 (en) | 2000-10-16 | 2008-04-29 | Midatech Limited | Nanoparticles |
WO2002032404A3 (en) * | 2000-10-16 | 2002-08-22 | Consejo Superior Investigacion | Nanoparticles |
JP2009242418A (en) * | 2000-10-16 | 2009-10-22 | Consejo Superior De Investigaciones Cientificas | Nanoparticles |
WO2002032404A2 (en) * | 2000-10-16 | 2002-04-25 | Consejo Superior De Investigaciones Cientificas | Nanoparticles |
US8790934B2 (en) | 2000-10-16 | 2014-07-29 | Consejo Superior De Investigaciones Cientificas | Nanoparticles |
EP1671625A1 (en) * | 2000-10-16 | 2006-06-21 | Consejo Superior De Investigaciones Cientificas | Nanoparticles |
US8080431B2 (en) | 2000-10-16 | 2011-12-20 | Midatech Limited | Nanoparticles |
US6483125B1 (en) | 2001-07-13 | 2002-11-19 | North Carolina State University | Single electron transistors in which the thickness of an insulating layer defines spacing between electrodes |
US6653653B2 (en) | 2001-07-13 | 2003-11-25 | Quantum Logic Devices, Inc. | Single-electron transistors and fabrication methods in which a projecting feature defines spacing between electrodes |
US6784082B2 (en) | 2001-07-13 | 2004-08-31 | North Carolina State University | Methods of fabricating single electron transistors in which the thickness of an insulating layer defines spacing between electrodes |
US7563818B2 (en) | 2001-11-01 | 2009-07-21 | Cancer Research Technology Limited | Photosensitizer functionalised nanoparticles |
US6673717B1 (en) | 2002-06-26 | 2004-01-06 | Quantum Logic Devices, Inc. | Methods for fabricating nanopores for single-electron devices |
EP2486944A1 (en) * | 2003-06-09 | 2012-08-15 | Consejo Superior De Investigaciones Científicas | Magnetic nanoparticles |
US8557607B2 (en) | 2003-06-09 | 2013-10-15 | Consejo Superior De Investigacione Cientificas | Magnetic nanoparticles |
WO2004108165A3 (en) * | 2003-06-09 | 2005-06-16 | Consejo Superior Investigacion | Magnetic nanoparticles linked to a lingand |
EP2277548A3 (en) * | 2003-06-09 | 2011-04-27 | Consejo Superior De Investigaciones Cientificas | Magnetic nanoparticles linked to a ligand |
FR2859117A1 (en) * | 2003-08-27 | 2005-03-04 | Commissariat Energie Atomique | USE OF NANOPARTICLES WITH A METAL HEART AND DOUBLE ORGANIC COATING AS CATALYSTS AND NANOPARTICLES USEFUL AS CATALYSTS |
US7595108B2 (en) | 2003-08-27 | 2009-09-29 | Commissariat A L'energie Atomique | Nanoparticles comprising a metal core and an organic double coating useful as catalysts and device containing the nanoparticles |
JP4772677B2 (en) * | 2003-08-27 | 2011-09-14 | コミッサリア ア レネルジー アトミーク エ オ ゼネルジ ザルタナテイヴ | Use of nanoparticles having metal cores and organic double coatings as catalysts, and nanoparticles useful as catalysts |
JP2007503302A (en) * | 2003-08-27 | 2007-02-22 | コミツサリア タ レネルジー アトミーク | Use of nanoparticles having metal cores and organic double coatings as catalysts, and nanoparticles useful as catalysts |
WO2005021154A1 (en) * | 2003-08-27 | 2005-03-10 | Commissariat A L'energie Atomique | Use of nanoparticles with a metallic core and a double organic coating as catalysts, and nanoparticles used for same |
JP2008514686A (en) * | 2004-10-01 | 2008-05-08 | ミダテック リミテッド | Nanoparticles containing antigens and adjuvants, and immunogenic structures |
US8597397B2 (en) | 2005-01-14 | 2013-12-03 | Cabot Corporation | Production of metal nanoparticles |
CN1305977C (en) * | 2005-03-04 | 2007-03-21 | 北京化工大学 | Method for modifying the surface of nano inorganic particles by transfer method |
Also Published As
Publication number | Publication date |
---|---|
CA2329859A1 (en) | 1999-12-02 |
WO1999061911A3 (en) | 2000-03-09 |
EP1073902A2 (en) | 2001-02-07 |
AU6016999A (en) | 1999-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Templeton et al. | Gateway reactions to diverse, polyfunctional monolayer-protected gold clusters | |
Jia et al. | Bioactivity-protected electrochemiluminescence biosensor using gold nanoclusters as the low-potential luminophor and Cu2S snowflake as co-reaction accelerator for procalcitonin analysis | |
JP3791930B2 (en) | Graphite nanotubes in luminescence assays | |
Fox et al. | Fluorescence and redox activity of probes anchored through an aminotrithiol to polycrystalline gold | |
EP1042508B1 (en) | Methods for improved luminescence assays using microparticles | |
EP2286234B1 (en) | Novel au-ag core-shell composite useful for biosensor | |
NZ514682A (en) | Monolayer and electrode for detecting a label-bearing target and method of use thereof | |
Qi et al. | Functionalization of single-walled carbon nanotubes with protein by click chemistry as sensing platform for sensitized electrochemical immunoassay | |
CN110438200A (en) | A kind of biosensor for heavy metal lead ion detection based on dual signal amplification | |
JP2008502715A (en) | New DNA stitching intercalator | |
EP1073902A2 (en) | Nanometer particles containing a reactive monolayer | |
Taira et al. | Electrode modification by long-chain, dialkyl disulfide reagent having terminal dinitrophenyl group and its application to impedimetric immunosensors | |
US20040048272A1 (en) | Dendritically amplified detection method | |
US9157161B1 (en) | Multifunctional thin film surface | |
JP2004022424A (en) | Material for photoelectric transducing element containing host-guest complex | |
Ahmadpor et al. | A comparative study of different techniques for quantum dot nano-particles immobilization on glass surface for fabrication of solid phase fluorescence opto-sensors | |
US7321831B2 (en) | Nucleic acid fragment-fixed electrode and its use | |
Lu et al. | The characterization of 5-{[4-(4-mercapto) phenylmethoxy] phenyl}-10, 15, 20-tris (phenyl) porphyrin cobalt (II) self-assembled monolayers (SAMs) and its electrocatalytic oxidation for ascorbic acid | |
Wang et al. | Polyviologen synthesis by self-assembly assisted grafting | |
WO2020232353A1 (en) | Sensors and methods using electrochemiluminescence of metal nanoclusters | |
US7005268B2 (en) | Detection of biopolymers utilizing photo-initiated charge separation | |
Adams | Luminescent surface-active transition metal complexes as probes for sensing and supramolecular recognition architectures | |
Tabassum et al. | Future and commercialization aspects of photoelectrochemical bioanalysis | |
US20080166712A1 (en) | Gene detection method | |
Carducci et al. | 3 Electrochemistry of Monolayer-Protected Clusters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
NENP | Non-entry into the national phase in: |
Ref country code: KR |
|
ENP | Entry into the national phase in: |
Ref document number: 2329859 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999953384 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999953384 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999953384 Country of ref document: EP |